Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2667)
All Articles published online
|
Aug 14, 2006 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Büning C, Lochs H. Conventional therapy for Crohn’s disease. World J Gastroenterol 2006; 12(30): 4794-4806 [PMID: 16937460 DOI: 10.3748/wjg.v12.i30.4794] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i30/4794.htm |
| Number | Citing Articles |
| 1 |
Javier P. Gisbert, Fernando Gomollón. Errores frecuentes en el manejo del paciente ambulatorio con enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 2007; 30(8): 469 doi: 10.1157/13110491
|
| 2 |
Sharon Dudley-Brown, Arpita Nag, Cory Cullinan, Mary Ayers, Steve Hass, Sumeet Panjabi. Health-Related Quality-of-Life Evaluation of Crohn Disease Patients After Receiving Natalizumab Therapy. Gastroenterology Nursing 2009; 32(5): 327 doi: 10.1097/SGA.0b013e3181bb1484
|
| 3 |
Mahnaz Fatahzadeh. Inflammatory bowel disease. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 2009; 108(5): e1 doi: 10.1016/j.tripleo.2009.07.035
|
| 4 |
Dorota Wójcik-Pastuszka, Aleksandra Potempa, Witold Musiał. Bipolymeric Pectin Millibeads Doped with Functional Polymers as Matrices for the Controlled and Targeted Release of Mesalazine. Molecules 2020; 25(23): 5711 doi: 10.3390/molecules25235711
|
| 5 |
G. Rogler. Inflammatory Bowel Disease — Diagnostic and Therapeutic Strategies. Falk Symposium 2007; 154: 165 doi: 10.1007/978-1-4020-6116-5_18
|
| 6 |
J. Gapasin, D. R. Van Langenberg, G. Holtmann, D. J. Hetzel, J. M. Andrews. Potentially avoidable surgery in inflammatory bowel disease: what proportion of patients come to resection without optimal preoperative therapy? A guidelines‐based audit. Internal Medicine Journal 2012; 42(5) doi: 10.1111/j.1445-5994.2010.02328.x
|
| 7 |
Claudia Pena Rossi, Stephen B Hanauer, Ratko Tomasevic, John O Hunter, Ira Shafran, Hans Graffner. Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study. BMC Gastroenterology 2009; 9(1) doi: 10.1186/1471-230X-9-22
|
| 8 |
Ira Shafran, Patricia Burgunder. Adjunctive Antibiotic Therapy with Rifaximin May Help Reduce Crohn’s Disease Activity. Digestive Diseases and Sciences 2010; 55(4): 1079 doi: 10.1007/s10620-009-1111-y
|
| 9 |
Ichiro Moriyama, Shunji Ishihara, M Azharul Karim Rumi, M D Monowar Aziz, Yoshiyuki Mishima, Naoki Oshima, Chikara Kadota, Yasunori Kadowaki, Yuji Amano, Yoshikazu Kinoshita. Decoy oligodeoxynucleotide targeting activator protein-1 (AP-1) attenuates intestinal inflammation in murine experimental colitis. Laboratory Investigation 2008; 88(6): 652 doi: 10.1038/labinvest.2008.38
|
| 10 |
Javier P. Gisbert, Fernando Gomollón. Errores frecuentes en el manejo del paciente grave con enfermedad inflamatoria intestinal. Gastroenterología y Hepatología 2007; 30(5): 294 doi: 10.1157/13101982
|